Fujitsu Frontech North America Inc., a leading supplier of innovative computer products including peripherals and biometric security solutions, today announced that Holy Name Hospital in Teaneck, N.J. is the first hospital in New Jersey to implement the Fujitsu PalmSecure™ palm vein authentication technology for patient registration and identification. The Fujitsu PalmSecure biometric solution integrates into Holy Name's new Palm First registration system to bolster security of medical records and enhance the overall patient experience. The PalmSecure technology helps Holy Name prevent medical identify theft and comply with the Healthcare Insurance Portability and Accountability Act (HIPAA) while ensuring that patients receive care more efficiently. Fujitsu (booth #5232) will demonstrate the PalmSecure authentication solution during HIMSS10 Annual Conference & Exhibition, March 1-3, 2010 at the Georgia World Congress Center in Atlanta.
InfraReDx, Inc., an innovative medical device company focused on developing novel diagnostic imaging technologies to accurately identify and characterize diseased intracoronary tissues, today announced that the Company will be exhibiting at LUMEN 2010, the world's premier ST-elevation myocardial infarction (STEMI) meeting, to be held February 25-27, 2010 at the Loews Miami Beach Hotel in Miami Beach, Florida. The 9th Annual LUMEN meeting is an educational symposium providing updates from world-renowned experts in key areas of interventional cardiology and vascular intervention. InfraReDx will be displaying its novel LipiScan™ Coronary Imaging System at booth #306 throughout the LUMEN meeting. InfraReDx will be available to discuss with attending clinical and interventional cardiologists, cardiac and vascular surgeons and other cardiovascular professionals LipiScan's abilities in identifying and characterizing lipid core (fatty) plaques and the importance of this novel technology.
inVisionCam™ to be demonstrated at ADEA Annual Session & Exhibition, March 1-2
Of the 200,000 men newly diagnosed with prostate cancer each year in the United States, about one-third will undergo surgical treatment. Although open radical prostatectomy (ORP) is regarded as the standard treatment, laparoscopic radical prostatectomy (LRP) with or without robotic assistance is becoming more common.
Early tumor formation in Barrett's esophagus (BE) can be effectively and safely treated with radiofrequency ablation (RFA), in combination with prior endoscopic removal of visible lesions, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute.
The combined U.S. market for dental lasers will grow at a CAGR of 6.1% over the forecast period. The market is expected to grow as the popularity of diode lasers continues to increase, driving the number of units sold. Dental surgical lasers represent a large majority of the overall dental lasers market and as a result, trends in the surgical lasers market will affect the behavior of the overall market.
Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce the Company has designed and is set to develop a new polymer dilator for the MammoView™ Breast Endoscopy System. The MammoView™ System currently offers a dilator set with a metal housing. The newly redesigned dilator utilizes a polymer housing, which is significantly softer while still offering comparable durability to the metal dilator. The new polymer dilator will be offered in addition to the more commonly used metal dilator. The two versions of the dilator offer physicians options based on individual patient's requirements.
Biotech company to stay and grow in the park, CEO remains in place
Arizona State University scientists have come up with a new twist in their efforts to develop a faster and cheaper way to read the DNA genetic code
AMETEK, Inc. (NYSE: AME) announced it has acquired the assets of Sterling Ultra Precision, a privately held reseller of machine tools for the ophthalmic lens market. Sterling Ultra Precision is headquartered in Tampa, FL.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.